Cargando…

Efficacy of a Trial Oral Appliance in OSAS Management: A New Protocol to Recognize Responder/Nonresponder Patients

Oral appliances (OAs) of various types have shown variable success in the treatment of mild-to-moderate obstructive sleep apnoea (OSA). In an OSA sample, this study evaluated the efficacy of a diagnostic trial OA (myTAP™); the efficacy of a definitive custom-fitted mandibular advancement device (MAD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Segù, Marzia, Cosi, Alessia, Santagostini, Antonio, Scribante, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225417/ https://www.ncbi.nlm.nih.gov/pubmed/34221017 http://dx.doi.org/10.1155/2021/8811700

Ejemplares similares

Update on Oral Appliance Therapy for OSA
por: Marklund, M.
Publicado: (2017)

O026 Effect of oral appliance therapy on OSA endotypes
por: Osman, A, et al.
Publicado: (2022)

Identifying responders and nonresponders to interferon therapy in multiple sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

The Interaction of Craniofacial Morphology and Body Mass Index in Obstructive Sleep Apnea
por: Bertuzzi, Federica, et al.
Publicado: (2022)

Short‐term GAA loading: Responders versus nonresponders analysis
por: Ostojic, Sergej M.
Publicado: (2020)

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β
por: Bustamante, Marta F., et al.
Publicado: (2015)

Adaptive differentiation of murine lymphocytes. IV. (Responder × Nonresponder) F(1) T cells can be taught to preferentially help nonresponder,rather than responder, B cells
por: Katz, DH, et al.
Publicado: (1979)

Pilot Study of a New Mandibular Advancement Device
por: Segù, Marzia, et al.
Publicado: (2022)

P031 A Novel Oral Appliance Implementation Protocol Using Nightly Portable Monitoring for OSA Patients Failing CPAP therapy
por: Ling, I, et al.
Publicado: (2023)

Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept
por: Koczan, Dirk, et al.
Publicado: (2008)

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy
por: Peng, Xiaomei, et al.
Publicado: (2011)

Responders and nonresponders to topical capsaicin display distinct temporal summation of pain profiles
por: Wong, Felyx, et al.
Publicado: (2023)

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
por: Silberstein, Stephen D., et al.
Publicado: (2020)

An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease
por: Rutkowski, D., et al.
Publicado: (2015)

Low intensity extracorporeal shockwave Therapy shifts PDE5i nonresponders to responders
por: Wang, Jiamin, et al.
Publicado: (2020)

Self-Reported Complications after Tonsillectomy: Comparison of Responders and Nonresponders to a Mailed Questionnaire
por: Haye, Rolf, et al.
Publicado: (2020)

Linking Federal Administrative Records to Respondents and Nonrespondents in Household Surveys: A Case Study
por: Sakshaug, Joseph, et al.
Publicado: (2017)

Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
por: Neldam, Steen, et al.
Publicado: (2013)

Generation of T cell colonies from responder strain 2 guinea pigs that recognize the copolymer L-glutamic acid, L-lysine in association with nonresponder strain 13 Ia antigens
Publicado: (1982)

Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode
por: Belzeaux, R, et al.
Publicado: (2012)

Haplotype Analysis of GSK-3β Gene Polymorphisms in Bipolar Disorder Lithium Responders and Nonresponders
por: Iwahashi, Kazuhiko, et al.
Publicado: (2014)

P004 Addition of an oral expiratory positive pressure valve (EPAP) to an oral appliance therapy device can resolve obstructive sleep aponea (OSA)
por: Aishah, A, et al.
Publicado: (2022)

Cell‐Based Therapies: The Nonresponder
por: Caplan, Arnold I.
Publicado: (2018)

Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains
Publicado: (1981)

IGF and IGFBP as an index for discrimination between vitamin D supplementation responders and nonresponders in overweight Saudi subjects
por: Al-Daghri, Nasser M., et al.
Publicado: (2018)

Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders
por: Theunissen, Eef L., et al.
Publicado: (2019)

Psychological Distress in Responders and Nonresponders in a 5-year Follow-up Health Survey: The RIAS Study
por: Tsubota-Utsugi, Megumi, et al.
Publicado: (2022)

High-frequency rTMS in the treatment of depressive symptoms in schizophrenia: a neurophysiological profile of respondents and nonresponders
por: Kaleda, V., et al.
Publicado: (2022)

Customized Minimally Invasive Protocols for the Clinical and Microbiological Management of the Oral Microbiota
por: Scribante, Andrea, et al.
Publicado: (2022)

THE BEHAVIOR OF HAPTEN-POLY-L-LYSINE CONJUGATES AS COMPLETE ANTIGENS IN GENETIC RESPONDER AND AS HAPTENS IN NONRESPONDER GUINEA PIGS
por: Green, Ira, et al.
Publicado: (1966)

Differential systemic gene expression profile in patients with diabetic macular edema: Responders versus nonresponders to standard treatment
por: Dabir, Supriya S, et al.
Publicado: (2014)

Characterization of Metabolic Parameters in Responders and Nonresponders Treated with Canagliflozin Monotherapy in Drug-naive Subjects with Type 2 Diabetes
por: Kutoh, Eiji, et al.
Publicado: (2018)

Distinctively different predictors for long‐term outcomes between responders and nonresponders who underwent cardiac resynchronization therapy
por: Yufu, Kunio, et al.
Publicado: (2020)

Correlation between Parental-Reported Tooth Grinding and Sleep Disorders: Investigation in a Cohort of 741 Consecutive Children
por: Segù, M., et al.
Publicado: (2020)

New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy
por: Gerber, Scott, et al.
Publicado: (2023)

New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy
por: Uccello, Taylor P., et al.
Publicado: (2023)

Efficacy of a mandibular advancement intraoral appliance (MOA) for the treatment of obstructive sleep apnea syndrome (OSAS) in pediatric patients: A pilot-study
por: Modesti-Vedolin, Gabriela, et al.
Publicado: (2018)

Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytes
Publicado: (1975)

COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
por: Kaminski, Hannah, et al.
Publicado: (2022)

Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L- tyrosine10 (GAT) II. Cellular source and effect on responder and nonresponder mice
Publicado: (1977)

Cannot write session to /tmp/vufind_sessions/sess_4565vfn6k50ep0dgrtvf6f6s89